One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The Platinum Hall of Fame
doi : 10.1016/j.eururo.2023.11.005
Volume 85, Issue 1, January 2024, Pages e1-e11
Are PARP Inhibitors Ready for Prime Time in Metastatic Prostate Cancer? Maybe Not
Daniel A. Gonza´lez-Padilla a,*, Jose´ Daniel Subiela
doi : 10.1016/j.eururo.2023.05.017
Volume 85, Issue 1, January 2024, Pages 1-2
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
Christopher J. Logothetis *, Andrew W. Hahn
doi : 10.1016/j.eururo.2023.04.015
Volume 85, Issue 1, January 2024, Pages 3-7
Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial
Marc-Oliver Grimm a,*, Mototsugu Oya b , Toni K. Choueiri c , Robert J. Motzer d , Manuela Schmidinger e , David I. Quinn f , Gwenaelle Gravis-Mescam g , Elena Verzoni h , Alfonsus J.M. Van den Eertwegh i , Alessandra di Pietro j , Mariangela Mariani j , Jing Wang k , Despina Thomaidou l , Laurence Albiges m
doi : 10.1016/j.eururo.2023.09.016
Volume 85, Issue 1, January 2024, Pages 8-12
How Well Do Artificial Intelligence Chatbots Respond to the Top Search Queries About Urological Malignancies?
David Musheyev a,y, Alexander Pan a,y, Stacy Loeb b,c , Abdo E. Kabarriti a,*
doi : 10.1016/j.eururo.2023.07.004
Volume 85, Issue 1, January 2024, Pages 13-16
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
J. Alfred Witjes a,*, Harman Max Bruins b , Albert Carrio´n c , Richard Cathomas d , Eva Compe´rat e , Jason A. Efstathiou f , Rainer Fietkau g , Georgios Gakis h , Anja Lorch i , Alberto Martini j,k , Laura S. Mertens l , Richard P. Meijer m , Matthew I. Milowsky n , Yann Neuzillet o , Valeria Panebianco p , John Redlef q , Michael Rink r , Mathieu Rouanne o , George N. Thalmann s , S?bj?rn S?bj?rnsen q , Erik Veskima¨e t , Antoine G. van der Heijden
doi : 10.1016/j.eururo.2023.08.016
Volume 85, Issue 1, January 2024, Pages 17-31
The 2023 European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: A Critical Appraisal
Patrick J. Hensley a , Ananya Choudhury b,c , Ali Raza Khaki d , Petros Grivas e , Ashish M. Kamat f,*
doi : 10.1016/j.eururo.2023.10.010
Volume 85, Issue 1, January 2024, Pages 32-34
The Role of Multiparametric MRI and MRI–targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial
Alexander Light a,b , Abi Kanthabalan c , Marjorie Otieno c , Menelaos Pavlou d , Rumana Omar d , Sola Adeleke e,f , Francesco Giganti c,g , Chris Brew-Graves h , Norman R. Williams c , Amr Emara i , Athar Haroon j,k , Arash Latifoltojar h,l , Harbir Sidhu g,h , Alex Freeman m , Clement Orczyk c,n , Ashok Nikapota o , Tim Dudderidge p , Richard G. Hindley i , Jaspal Virdi q , Manit Arya b , Heather Payne m , Anita V. Mitra r , Jamshed Bomanji k , Mathias Winkler a,b , Gail Horan s , Caroline M. Moore c,n , Mark Emberton c,n , Shonit Punwani g,h , Hashim U. Ahmed a,b,c,y, Taimur T. Shah
doi : 10.1016/j.eururo.2023.09.001
Volume 85, Issue 1, January 2024, Pages 35-46
Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging–visible Disease in Radiorecurrent Prostate Cancer
Amar U. Kishan a,b,*, Luca F. Valle a,c , Leonard S. Marks
doi : 10.1016/j.eururo.2023.09.018
Volume 85, Issue 1, January 2024, Pages 47-48
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer
doi : 10.1016/j.eururo.2023.09.003
Volume 85, Issue 1, January 2024, Pages 49-60
The Pythia Speaks on Prostate Cancer Diagnosis and Treatment
Rodney J. Hicks *
doi : 10.1016/j.eururo.2023.09.021
Volume 85, Issue 1, January 2024, Pages 61-62
The Role of 99mTc�Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta�analysis
Giuseppe Basile a,b,*, Giuseppe Fallara c , Paolo Verri b , Alessandro Uleri b , Arturo Chiti d , Luigi Gianolli d , Gino Pepe d , Alessandro Tedde b,f , Ferran Algaba e , Angelo Territo b , Francesco Sanguedolce b,f , Alessandro Larcher a , Andrea Gallioli b , Joan Palou b , Francesco Montorsi a , Umberto Capitanio a , Alberto Breda
doi : 10.1016/j.eururo.2023.07.013
Volume 85, Issue 1, January 2024, Pages 63-71
Preoperative Risk Stratification of Renal Neoplasia: Are Classification Semantics Hindering Progress?
Jesse K. McKenney
doi : 10.1016/j.eururo.2023.10.003
Volume 85, Issue 1, January 2024, Pages 72-73
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam
Ivo I. de Vos *, Sebastiaan Remmers, Rene´e Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group
doi : 10.1016/j.eururo.2023.10.011
Volume 85, Issue 1, January 2024, Pages 74-81
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer
Trine Strandgaard a,b , Iver Nordentoft a , Karin Birkenkamp-Demtro¨der a,b , Liina Salminen a,b,c , Frederik Prip a,b , Julie Rasmussen a,b , Tine Ginnerup Andreasen a,b , Sia Viborg Lindskrog a,b , Emil Christensen a,b , Philippe Lamy a , Michael Knudsen a , Torben Steiniche b,d , J?rgen Bjerggaard Jensen b,e , Lars Dyrskj?t
doi : 10.1016/j.eururo.2023.07.014
Volume 85, Issue 1, January 2024, Pages 82-92
Re: Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial
Mikkel Fode a,b,* Christian Fuglesang S. Jensen a Jens S?nksen
doi : 10.1016/j.eururo.2023.08.018
Volume 85, Issue 1, January 2024, Page 93
Re: Application of Suctioning Ureteral Access Sheath During Flexible Ureteroscopy for Renal Stones Decreases the Risk of Postoperative Systemic Inflammatory Response Syndrome
Petris?or Geavlete * Ra?zvan Mult?escu Bogdan Geavlete
doi : 10.1016/j.eururo.2023.08.020
Volume 85, Issue 1, January 2024, Page 94
Re: Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve
Christopher Netsch
doi : 10.1016/j.eururo.2023.08.024
Volume 85, Issue 1, January 2024, Pages 94-95
Re: Genetically Adjusted PSA Levels for Prostate Cancer Screening
Martin C. Michel
doi : 10.1016/j.eururo.2023.08.019
Volume 85, Issue 1, January 2024, Pages 95-96
Re: Niraparib and Abiraterone Acetate for Metastatic Castration-resistant Prostate Cancer
Edward Lambert a,b,c Morgan Rouprêt
doi : 10.1016/j.eururo.2023.09.012
Volume 85, Issue 1, January 2024, Pages 96-97
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial
Matteo Rosellini a,b,y Elisa Tassinari a,b,y Andrea Marchetti a,b Veronica Mollica a,b Francesco Massari
doi : 10.1016/j.eururo.2023.09.011
Volume 85, Issue 1, January 2024, Pages 97-98
Reply to Xiao Li, Zicheng Xu, and Feng Qi’s Letter to the Editor re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571–9
Soumyajit Roy a,* Yilun Sun b Scott Morgan c Shawn Malone
doi : 10.1016/j.eururo.2023.08.005
Volume 85, Issue 1, January 2024, Pages e12-e13
Re: Soumyajit Roy, Yilun Sun, Scott C. Morgan, et al. Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. Eur Urol 2023;83:571–9
Xiao Li Zicheng Xu Feng Qi
doi : 10.1016/j.eururo.2023.06.034
Volume 85, Issue 1, January 2024, Page e14
Reply to Qingpeng Xie and Dianqiu Shen’s Letter to the Editor re: Bhavan P. Rai, José Luis Dominguez Escrig, LuÃs Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol 2022;82:182–92
Bhavan Prasad Rai a,* Philippe D. Violette b,c Muhammad Imran Omar
doi : 10.1016/j.eururo.2023.09.019
Volume 85, Issue 1, January 2024, Pages e15-e16
Re: Bhavan P. Rai, José Luis Dominguez Escrig, LuÃs Vale, et al. Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria. Eur Urol 2022;82:182–92
Qingpeng Xie Dianqiu Shen
doi : 10.1016/j.eururo.2023.09.030
Volume 85, Issue 1, January 2024, Pages e17-e18
Re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol. 2023;41:4406–4415
Thomas Seisen a,* Morgan Rouprêt a Quoc-Dien Trinh b Joaquim Bellmunt
doi : 10.1016/j.eururo.2023.09.028
Volume 85, Issue 1, January 2024, Pages e19-e21
Reply to Thomas Seisen, Morgan Rouprêt, Quoc-Dien Trinh, and Joaquim Bellmunt’s Letter to the Editor re: Martin Swinton, Neethu Billy Graham Mariam, Jean Ling Tan, et al. Bladder-Sparing Treatment with Radical Dose Radiotherapy Is an Effective Alternative to Radical Cystectomy in Patients with Clinically Node-positive Nonmetastatic Bladder Cancer. J Clin Oncol 2023;41:4406–15
Martin Swinton a,b,* Peter Hoskin b Ananya Choudhury
doi : 10.1016/j.eururo.2023.10.004
Volume 85, Issue 1, January 2024, Pages e22-e23
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669–81
Thomas Seisen a,* Morgan Rouprêt a Pierre Blanchard
doi : 10.1016/j.eururo.2023.07.019
Volume 85, Issue 1, January 2024, Page e24
Reply to Thomas Seisen, Morgan Rouprêt, and Pierre Blanchard’s Letter to the Editor re: Alexandre R. Zlotta, Leslie K. Ballas, Andrzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669–81
Alexandre R. Zlotta a,b,* Katherine Lajkosz c Jason A. Efstathiou
doi : 10.1016/j.eururo.2023.08.011
Volume 85, Issue 1, January 2024, Pages e25-e26
Erratum to “Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion� [Eur. Urol. 75(5) (2019) 752–763]
Qiang Fu a,1, Le Xu b,1, Yiwei Wang c,1, Qi Jiang d,1, Zheng Liu e , Junyu Zhang e , Quan Zhou a , Han Zeng a , Shanyou Tong a , Tao Wang f , Yangyang Qi d , Baoying Hu a , Hangcheng Fu e , Huyang Xie e , Lin Zhou f , Yuan Chang e , Yu Zhu e , Bo Dai e,*, Weijuan Zhang d,*, Jiejie Xu
doi : 10.1016/j.eururo.2023.08.025
Volume 85, Issue 1, January 2024, Page e27
